Introduction
In its attempt to regulate interstate commerce of chemicals within the United States, Congress created five regulatory agencies with the burden of overseeing various aspects of that trade. The Environmental Protection Agency (EPA), the Consumer Product Safety Commission (CPSC), the United States Department ofAgriculture/Food Safety and Inspection Service (USDA/FSIS) the U.S. Department of Labor and its Occupational Safety and Health Administration (OSHA) and the Food and Drug Administration (FDA) regulate the use of chemicals in interstate commerce. Because each of these agencies arose through different enabling legislation and are concerned with a different use of chemicals, it is likely that the same chemical would be independently regulated by two or more of those agencies. In addition, because chemicals and their manufacture and use, in general, are a concern of each of those agencies, policies and requirements for safe use of those chemicals could be different for each agency. For the above reasons, in October 1977, at the urging of the executive branch, each of the agency heads of EPA, CPSC, FDA and OSHA agreed to recommend those specific areas in which interagency cooperation would be beneficial to all agencies. Some areas of concern were finally agreed upon by the agency heads.
In the area of toxicity testing guidelines, it was important for each agency to require similar standards to prevent duplicative testing by industry. also believed that an inspector from a single agency could observe the same territory as many inspectors from different agencies had previously. This attempt to coordinate inspection efforts was believed to increase the efficiency and reduce the burden of inspection on industry and government. Sixth, the agency heads wanted to determine ifthere were sufficient resources that could be pooled to develop a uniform federal government agency response to problems of common concern to two or more agencies. Communication and education were considered important because it was felt that information transmitted to the public on toxic substances should be consistent, accurate, and educational. The development of a uniform policy for review of epidemiology data was the eighth area where the agency heads felt that there was common interest.
In October 1977, the agency heads formally announced the creation of the Interagency Regulatory Liaison Group (IRLG). The stated goal of that organization was "to increase the public health and protect the environment by sharing information, avoiding duplication of effort and developing consistent regulatory policy while reducing the burden on those regulated and the agencies themselves (1) .
It was decided to concentrate on research for regulation of hazardous substances on a nationwide basis. Some operating concepts are to avoid creating another level of bureaucracy, to focus on action, not studies. Coordination is the rule, not the exception. It was deemed important to be certain 
Organization of IRLG
IRLG as a group of agencies has only one fulltime employee. This is to reinforce the idea that agency employees are also members of the IRLG. Each member agency designates part of its operating budget for the funding of IRLG programs.
The IRLG is directed by the five agency heads. Day-to-day activities of the agencies are overseen by two surrogates from each agency. The substructure below the surrogates consists of regional staff, task groups, work groups, senior headquarters staff and operating staff, but there is no set organizational hierarchy as to how these groups interact. The organization is flexible to allow for unexpected emergencies where one group will be required to interact with another.
Regulatory development is one of the groups within working groups. It is a work group consisting of 20 subwork groups which each are concerned with a chemical of concern to at least two of the member agencies ( IRLG immediately responded by forming a new work group on plasticizers. Each Member agency appointed a representative (it should be apparent that if a particular agency had no interest in the regulation of a compound, it would not appoint a representative). Because of the diverse interests in plasticizers, the work group has had representatives of a number of non-IRLG agencies, including the Department of Defense (DOD), the National Toxicology Program (NTP), The National Institute of Occupational Health and Safety (NIOSH), and the Nuclear Regulatory Commission (NRC), attend its meetings. The work group agreed that DEHP, DEHA and BBP were of primary concern; however, any possible alternative for those compounds would also fall within the review by the work group. It was also of general consensus that all toxicology and exposure data available within an individual agency would be exchanged so that the same data base would be considered by all involved.
It was obvious that the data base for toxicity studies on phthalates was large. However, the only long-term studies on phthalates other than the recent NCI studies were completed in the middle 1950s. Although negative in terms of carcinogenicity, those studies were not conducted under present day testing standards. It was a concern of the IRLG scientist representing each agency that advice from outside the U.S. government on the generally accepted interpretation of those results be sought out. As a result, the work group agreed that a conference consisting of recognized experts in the field of phthalates and carcinogenesis could provide the work group and member agencies enough background on manufacturing, exposure, toxicology and testing rationale data so that regulatory decisions on the matter could be made by each agency.
Agreements were made between the NTP and IRLG who sponsored this conference on phthalates. The work group felt that a conference held prior to commencement of any formal regulatory action would allow participants to freely air their views without a cloud of pending regulatory activity which might restrict the free flow of ideas.
The information gained from the conference is presently being considered by the agencies and work group. The information was valuable and helped the work group understand many of the issues involved with the problem.
The workgroup is now continuing its efforts by working with the NTP and the Chemical Manufacturers Association to develop a clearinghouse for ongoing toxicological studies being conducted throughout the world. This program is presently being initiated and it is hopeful that it can prevent duplication of experimentation by scientists throughout the world and continue the open dialogue for discussion ofthe interpretation ofthese new results.
